E-LIB Suche - Ergebnisse für: Furey, Nika - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

A hepatitis B virus transgenic mouse model with a condition..:

Kruse, Robert L. ; Barzi, Mercedes ; Legras, Xavier...
JHEP Reports. 3 (2021) 2 - p. 100252 , 2021

Link: https://doi.org/10.1016/..

2

Antibacterial Mechanisms and Efficacy of Sarecycline in Ani..:

Bunick, Christopher G. ; Keri, Jonette ; Tanaka, S. Ken...
Antibiotics. 10 (2021) 4 - p. 439 , 2021

Link: https://doi.org/10.3390/..

3

Somatic Liver Knockout (SLiK): A Quick and Efficient Way to..:

Johnson, Collin G. ; Chen, Tong ; Furey, Nika..
Current Protocols in Molecular Biology. 130 (2020) 1 - p. , 2020

Link: https://doi.org/10.1002/..

4

Using CRISPR/Cas9 to model human liver disease:

Alves-Bezerra, Michele ; Furey, Nika ; Johnson, Collin G..
JHEP Reports. 1 (2019) 5 - p. 392-402 , 2019

Link: https://doi.org/10.1016/..

5

A hepatitis B virus transgenic mouse model with a condition..:

Robert L. Kruse ; Mercedes Barzi ; Xavier Legras...
http://www.sciencedirect.com/science/article/pii/S2589555921000288. , 2021

Link: https://doi.org/10.1016/..

6

Antibacterial Mechanisms and Efficacy of Sarecycline in Ani..:

Christopher G. Bunick ; Jonette Keri ; S. Ken Tanaka...
Antibiotics Use and Antimicrobial Stewardship. , 2021

Link: https://doi.org/10.3390/..

7

Antibacterial Mechanisms and Efficacy of Sarecycline in Ani..:

Christopher G. Bunick ; Jonette Keri ; S. Ken Tanaka...
https://www.mdpi.com/2079-6382/10/4/439. , 2021

Link: https://doi.org/10.3390/..

8

Antibacterial Mechanisms and Efficacy of Sarecycline in Ani..:

Christopher G. Bunick ; Jonette Keri ; S. Ken Tanaka...
info:eu-repo/semantics/altIdentifier/pmid/33920812. , 2021

Link: http://hdl.handle.net/24..

9

Using CRISPR/Cas9 to model human liver disease:

Michele Alves-Bezerra ; Nika Furey ; Collin G. Johnson.
http://www.sciencedirect.com/science/article/pii/S2589555919301077. , 2019

Link: https://doi.org/10.1016/..

1-9